Fingerprint
Dive into the research topics of 'Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically